New Report Confirms Pharma Reps Are Poorly Informed

CME providers are regularly urged to develop relationships with pharmaceutical company representatives, with the intent of teaching them about what is and is not acceptible practice in producing industry-supported CME. Those CME providers who complain that building such relationships has become impossible because of the proliferation of drug reps now have some numbers to back them up, courtesy of McKinsey & Company, the management consulting firm.

Register to view the full article

Register for and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.